Jan Schrooten is co-founder and CEO of Antleron. Previously as an academic and trained as a materials engineer, with a PhD in biomaterials and a business postgraduate, he scientifically focused on translational regenerative medicine. His work is disseminated in 180+ peer reviewed journals and conferences (h-index 52).